These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2611544)

  • 1. A study of the effects of desipramine treatment alone and in combination with L-triiodothyronine on 6-sulphatoxymelatonin excretion in depressed patients.
    Bearn J; Franey C; Arendt J; Checkley SA
    Br J Psychiatry; 1989 Sep; 155():341-7. PubMed ID: 2611544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output.
    Kennedy SH; Brown GM
    Psychiatry Res; 1992 Aug; 43(2):177-85. PubMed ID: 1410073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and thyroid hormone levels.
    Joffe RT; Singer W
    Acta Med Austriaca; 1992; 19 Suppl 1():96-7. PubMed ID: 1519466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine.
    Schwarcz G; Halaris A; Baxter L; Escobar J; Thompson M; Young M
    Am J Psychiatry; 1984 Dec; 141(12):1614-6. PubMed ID: 6439059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
    Veith RC; Bielski RJ; Bloom V; Fawcett JA; Narasimhachari N; Friedel RO
    J Clin Psychopharmacol; 1983 Feb; 3(1):18-27. PubMed ID: 6833519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 6-hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: validation of measurements in urine extracted from diapers.
    Laakso ML; Lindblom N; Kaipainen P; Kaski M
    Scand J Clin Lab Invest; 2005; 65(5):413-31. PubMed ID: 16081364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmethylimipramine treatment increases melatonin production in humans.
    Sack RL; Lewy AJ
    Biol Psychiatry; 1986 Apr; 21(4):406-10. PubMed ID: 3006804
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
    Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone levels before unsuccessful antidepressant therapy are associated with later response to T3 augmentation.
    Sokolov ST; Levitt AJ; Joffe RT
    Psychiatry Res; 1997 Mar; 69(2-3):203-6. PubMed ID: 9109188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of the mechanism of action of desipramine.
    Checkley SA; Slade AP; Shur E; Dawling S
    Br J Psychiatry; 1981 Mar; 138():248-51. PubMed ID: 6268238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK; Vegt M; Nolen WA
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between thyroid and pineal responses to antidepressant treatment.
    Brown GM; Singer W; Joffe R
    Depression; 1996; 4(2):73-6. PubMed ID: 9160644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine potentiation of fluoxetine in depressed patients.
    Joffe RT
    Can J Psychiatry; 1992 Feb; 37(1):48-50. PubMed ID: 1551045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients.
    Palazidou E; Papadopoulos A; Ratcliff H; Dawling S; Checkley SA
    Psychol Med; 1992 May; 22(2):309-15. PubMed ID: 1319597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants.
    Joffe RT; Singer W
    Psychiatry Res; 1990 Jun; 32(3):241-51. PubMed ID: 2201988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of desipramine upon melatonin and cortisol secretion in depressed and normal subjects.
    Thompson C; Mezey G; Corn T; Franey C; English J; Arendt J; Checkley SA
    Br J Psychiatry; 1985 Oct; 147():389-93. PubMed ID: 4075027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary excretion of 6-sulphatoxymelatonin in normal subjects: statistical approach to the influence of age and sex].
    Hendrick JC; Crasson M; Hagelstein MT; Bruls E; Legros JJ
    Ann Endocrinol (Paris); 2002 Feb; 63(1):3-7. PubMed ID: 11937975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
    Thase ME; Kupfer DJ; Jarrett DB
    J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.